AAPlasma is Awarded MDA Phase I SBIR

AAPlasma is proud to announce that we have been chosen by the Missile Defense Agency to receive funding as part of their 2022 Small Business Innovation Research (SBIR) program. In this project, AAPlasma will be working with the MDA to develop technology to increase America’s missile defense capabilities.

AAPlasma is proud to be working towards the continued safety of the United States, its deployed forces, allies, and friends. We thank the MDA for this opportunity.

Check back in to see updates on this project and our other projects!